Semaglutide: A Promising Ally Against Alzheimer’s?
In a groundbreaking study, researchers at Case Western Reserve School of Medicine have identified a potential new benefit of semaglutide, a widely used diabetes and weight-loss drug. According to their findings, semaglutide may significantly reduce the risk of Alzheimer’s disease in individuals with type 2 diabetes (T2D), outperforming seven other anti-diabetic medications.
Alzheimer’s disease, a devastating brain disorder that erodes memory and cognitive abilities, affects nearly 7 million Americans aged 65 and older, as reported by the Alzheimer’s Association. Alarmingly, it claims more lives annually than breast and prostate cancer combined.
Published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, the study suggests that T2D patients taking semaglutide had a markedly lower risk of developing Alzheimer’s disease. This trend was consistent across various subgroups, regardless of obesity status, gender, or age.
Semaglutide, a glucagon-like peptide receptor (GLP-1R) agonist, is the active ingredient in popular medications like Wegovy and Ozempic. It works by reducing hunger and regulating blood sugar levels in T2D patients.
Under the leadership of Rong Xu, a professor of biomedical informatics, the research team analyzed three years of electronic health records from nearly one million U.S. patients with T2D. Their statistical approach, which mimicked a randomized clinical trial, revealed that patients prescribed semaglutide had a significantly lower risk of Alzheimer’s compared to those on other anti-diabetic medications.
According to the CDC, Alzheimer’s disease results in approximately 120,000 deaths annually, ranking as the seventh-leading cause of death in the United States.
“This new study provides real-world evidence for semaglutide’s potential impact on Alzheimer’s disease,” Xu stated. “While preclinical research has hinted at its protective effects against neurodegeneration and neuroinflammation, our findings suggest the need for further exploration through randomized clinical trials.”
Despite these promising results, the study’s limitations prevent researchers from drawing definitive causal conclusions. Xu emphasized the importance of continued research into semaglutide’s potential as a treatment for this debilitating condition, encouraging further investigation into alternative drugs.
For more information, please contact Patty Zamora at [email protected].
More Articles
Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!
Cameron Academy is thrilled to offer the Free Annual Florida Real Estate Sales Associate 63-Hour Pre-License Course Livestream. This exclusive event is an opportunity for aspiring real estate professionals to gain expert instruction, access a comprehensive curriculum, and connect with a network of professionals in the industry. The course will be livestreamed from December 04-15, 2023, allowing you to participate from the comfort of your own home or office. Register now to secure your spot in this highly sought-after course. Spaces are limited, so early registration is highly recommended. Take the first step towards your real estate career today!
Coldwell Banker, a renowned real estate brand, has recently appointed Jason Waugh as the new president of Coldwell Banker Affiliates. In his new role, Waugh will be responsible for overseeing the brand's strategy, operations, and sales for its growing network of franchises. This appointment comes as Coldwell Banker aims to further strengthen its position in the real estate market. With an impressive background in the industry, Waugh brings a wealth of experience to his new position. Previously associated with Berkshire Hathaway HomeServices and Berkshire Hathaway Home Services Real Estate Professionals for 18 years, Waugh's expertise and leadership qualities make him an ideal fit for this role.
United Wholesale Mortgage (UWM), the country's leading lender, has increased its agency conforming loan limits to $750,000. This move, ahead of the Federal Housing Finance Agency's expected decision, applies to conventional and VA loans locked from October 11. The decision offers borrowers greater flexibility and access to larger loan amounts, with the benefits of conforming loans. These loans meet the guidelines set by government-sponsored enterprises like Fannie Mae and Freddie Mac, offering lower interest rates and more favorable terms compared to non-conforming or jumbo loans.
PNC Bank has implemented a cost-cutting strategy, leading to layoffs and a shift in focus towards expense management and strategic priorities. The bank aims to streamline operations, improve efficiency, and reallocate resources to align with long-term goals. Despite the layoffs, PNC Bank is committed to supporting affected employees during the transition period. Learn more about PNC Bank's strategy and its impact on the industry at Cameron Academy, a leading career education school.
Government-sponsored enterprise (GSE) loan buybacks have emerged as a significant issue for lenders in the mortgage market. The sudden increase in buybacks from entities like Fannie Mae and Freddie Mac is causing financial and operational strain among lenders. The rise in loan buybacks is largely due to stricter underwriting guidelines enforced by these GSEs. The impact of these buybacks is significant and far-reaching. Lenders not only face financial losses from repurchasing loans, but they also encounter operational challenges. The surge in loan buybacks has created uncertainty in the mortgage market, potentially slowing down the housing market. In response to the challenges posed by loan buybacks, lenders are implementing stricter underwriting practices and enhancing their quality control processes.
The housing market is currently witnessing an unusual trend - a deceleration in the growth of housing inventory, despite the rise in mortgage rates. This unexpected development has triggered concerns among potential buyers and industry experts. With mortgage rates climbing from their historic lows, the number of homes available for sale remains surprisingly stagnant. We investigate the factors contributing to this unexpected stagnation in inventory growth and examine the implications of rising mortgage rates, limited new listings, and an increase in price cuts. We also consider the impact of external elements such as labor reports and geopolitical risks on the housing market.
